Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDXCNASDAQ:CRONNASDAQ:TLRYNYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXCChromaDex$6.16$2.31▼$9.18$611.50M2.21703,490 shs554,788 shsCRONCronos Group$1.71-3.9%$1.91$1.68▼$3.14$654.13M1.021.55 million shs2.38 million shsTLRYTilray$0.59-4.2%$0.81$0.55▼$2.97$555.28M1.8829.96 million shs22.18 million shsUSNAUSANA Health Sciences$25.50+0.1%$30.55$22.25▼$49.78$482.02M1113,032 shs226,252 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXCChromaDex0.00%0.00%+40.45%+42.74%+99.11%CRONCronos Group-1.66%-2.73%-11.88%-14.01%-38.19%TLRYTilray-4.94%-13.46%-10.98%-57.39%-78.32%USNAUSANA Health Sciences-6.09%-9.33%-14.11%-29.43%-43.83%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDXCChromaDex3.9956 of 5 stars3.54.00.04.00.60.01.9CRONCronos Group1.4854 of 5 stars2.54.00.00.01.40.01.3TLRYTilray1.4959 of 5 stars3.22.00.00.01.40.01.3USNAUSANA Health Sciences4.5362 of 5 stars3.02.00.03.11.51.75.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDXCChromaDex 3.00Buy$9.03∞ UpsideCRONCronos Group 1.00Sell$3.0076.99% UpsideTLRYTilray 2.40Hold$2.70365.52% UpsideUSNAUSANA Health Sciences 2.00Hold$36.0042.68% UpsideCurrent Analyst Ratings BreakdownLatest TLRY, CRON, CDXC, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/17/2025CDXCChromaDexHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.003/10/2025CDXCChromaDexHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.00 ➝ $11.003/5/2025CDXCChromaDexLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$6.80 ➝ $8.102/27/2025USNAUSANA Health SciencesDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$38.00 ➝ $36.002/18/2025USNAUSANA Health SciencesSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold1/13/2025TLRYTilrayCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy$2.00 ➝ $3.00(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDXCChromaDex$99.60M0.00N/AN/A$0.38 per share0.00CRONCronos Group$117.62M5.51N/AN/A$2.87 per share0.59TLRYTilray$210.48M2.58N/AN/A$4.14 per share0.14USNAUSANA Health Sciences$854.50M0.56$3.46 per share7.29$25.99 per share0.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDXCChromaDex-$4.94M$0.10787.290.00N/A1.62%4.85%2.70%5/6/2025 (Estimated)CRONCronos Group-$73.96M$0.10N/A56.501.74-42.65%-2.56%-2.47%5/8/2025 (Estimated)TLRYTilray-$244.98M-$0.30N/AN/AN/A-30.95%-4.40%-3.57%4/8/2025 (Estimated)USNAUSANA Health Sciences$63.79M$2.198.928.730.936.30%10.64%8.48%4/29/2025 (Estimated)Latest TLRY, CRON, CDXC, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025N/AUSNAUSANA Health Sciences$0.74N/AN/AN/A$243.08 millionN/A4/8/2025N/ATLRYTilray-$0.04N/AN/AN/A$213.38 millionN/A2/25/2025Q4 2024USNAUSANA Health Sciences$0.49$0.64+$0.15$0.23$208.82 million$213.61 million1/10/2025Q2 2025TLRYTilray-$0.03-$0.10-$0.07-$0.10$216.34 million$210.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDXCChromaDexN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATLRYTilrayN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDXCChromaDexN/A2.952.35CRONCronos GroupN/A24.2423.05TLRYTilray0.102.541.58USNAUSANA Health SciencesN/A3.933.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDXCChromaDex15.41%CRONCronos Group8.71%TLRYTilray9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCDXCChromaDex9.64%CRONCronos Group6.90%TLRYTilray0.87%USNAUSANA Health Sciences0.33%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDXCChromaDex12077.75 million69.02 millionOptionableCRONCronos Group450382.53 million356.14 millionOptionableTLRYTilray2,650937.66 million929.50 millionOptionableUSNAUSANA Health Sciences1,90018.91 million19.00 millionOptionableTLRY, CRON, CDXC, and USNA HeadlinesRecent News About These CompaniesUSANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for HarmonyApril 1 at 7:47 AM | prnewswire.com1 Russell 2000 Stock with Exciting Potential and 2 to AvoidApril 1 at 4:55 AM | theglobeandmail.comPersonal Care Stocks Q4 Teardown: USANA (NYSE:USNA) Vs The RestMarch 28, 2025 | msn.comUSANA Health Sciences (NYSE:USNA) Shares Up 3.8% - Should You Buy?March 27, 2025 | marketbeat.comUSANA Health Sciences (NYSE:USNA) Sets New 1-Year Low - Here's What HappenedMarch 26, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Decreases Stock Holdings in USANA Health Sciences, Inc. (NYSE:USNA)March 26, 2025 | marketbeat.comAt US$27.31, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?March 23, 2025 | finance.yahoo.com3 Reasons USNA is Risky and 1 Stock to Buy InsteadMarch 19, 2025 | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low - Here's What HappenedMarch 19, 2025 | marketbeat.comUSANA Health Sciences (NYSE:USNA) Trading Down 2.1% After Insider SellingMarch 15, 2025 | marketbeat.comJoshua Foukas Sells 5,732 Shares of USANA Health Sciences, Inc. (NYSE:USNA) StockMarch 14, 2025 | marketbeat.comUSANA Health Sciences, Inc. (NYSE:USNA) Insider Joshua Foukas Sells 5,732 SharesMarch 14, 2025 | insidertrades.comInsider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 500 Shares of StockMarch 13, 2025 | marketbeat.comJohn Turman Fleming Sells 500 Shares of USANA Health Sciences, Inc. (NYSE:USNA) StockMarch 13, 2025 | insidertrades.comInsider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells 3,234 Shares of StockMarch 12, 2025 | marketbeat.comUSANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $106,657.32 in StockMarch 12, 2025 | insidertrades.comGilbert A. Fuller Sells 674 Shares of USANA Health Sciences, Inc. (NYSE:USNA) StockMarch 11, 2025 | marketbeat.comPzena Investment Management LLC Increases Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)March 11, 2025 | marketbeat.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 674 SharesMarch 11, 2025 | insidertrades.comUSANA Health Sciences (NYSE:USNA) Stock Price Up 4.8% - Time to Buy?March 7, 2025 | marketbeat.comUSANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by Rhumbline AdvisersMarch 5, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockMicron Stock Spikes 7%—3 Key Catalysts Behind the MoveBy Thomas Hughes | March 13, 2025View Micron Stock Spikes 7%—3 Key Catalysts Behind the MoveMicron Stock Will Retest All-Time Highs This YearBy Thomas Hughes | March 21, 2025View Micron Stock Will Retest All-Time Highs This YearThese 3 Q1 Earnings Winners Will Go HigherBy Nathan Reiff | March 10, 2025View These 3 Q1 Earnings Winners Will Go Higher3 Undervalued Stocks You Can Buy at a Discount NowBy Gabriel Osorio-Mazilli | March 13, 2025View 3 Undervalued Stocks You Can Buy at a Discount NowTLRY, CRON, CDXC, and USNA Company DescriptionsChromaDex NASDAQ:CDXCChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.Cronos Group NASDAQ:CRON$1.71 -0.07 (-3.93%) Closing price 04:00 PM EasternExtended Trading$1.70 -0.01 (-0.88%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Tilray NASDAQ:TLRY$0.59 -0.03 (-4.16%) Closing price 04:00 PM EasternExtended Trading$0.59 0.00 (-0.20%) As of 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$25.50 +0.03 (+0.11%) Closing price 03:59 PM EasternExtended Trading$25.48 -0.02 (-0.09%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Sportsman’s Warehouse Trading Volume Spike Signals Opportunity Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Arm Holdings Aims for 50% Data Center Market Share Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
